TITLE:
Alternate Day Buprenorphine Administration, Phase XI - 16

CONDITION:
Opioid-Related Disorders

INTERVENTION:
Buprenorphine

SUMMARY:

      The purpose of this study is to evaluate open buprenorphine dosing with dose choice after
      open exposure.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 25 Years to 51 Years
Criteria:

        Please contact site for information.
      
